Ironwood Pharma (IRWD) Posts Mixed Q1 Results

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.34), $0.10 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $12.25 million versus the consensus estimate of $9.48 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Hertz cuts guidance, announces notes and stock offerings, shares sink
• More trouble for SpaceX? Analyst flags robotics and space as key bubble risk areas
• Tech eyes recovery after selloff, Micron to report results - What’s moving markets